Stocks and Investing
Stocks and Investing
Mon, August 14, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, August 11, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Stephen Brozak Upgraded (CDTX) to Hold on, Aug 11th, 2017
Stephen Brozak of WBB Securities, Upgraded "Cidara Therapeutics, Inc." (CDTX) to Hold on, Aug 11th, 2017.
Stephen has made no other calls on CDTX in the last 4 months.
There are 3 other peers that have a rating on CDTX. Out of the 3 peers that are also analyzing CDTX, 0 agree with Stephen's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Stephen
- Laura Chico of "Raymond James" Initiated at Strong Buy and Held Target at $280 on, Friday, April 21st, 2017
- Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $280 on, Monday, April 17th, 2017
- Kevin DeGeeter of "Ladenburg Thalmann" Initiated at Strong Buy and Held Target at $225 on, Wednesday, April 12th, 2017
Contributing Sources